GSK’s asthma blockbuster Nucala secures win in COPD Phase III trial
GSK is adding more strings to Nucala’s bow as the drug’s sales continue to grow.
06 September 2024
06 September 2024
GSK is adding more strings to Nucala’s bow as the drug’s sales continue to grow.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.